From professional translators, enterprises, web pages and freely available translation repositories.
alemtuzumabas
alemtuzumab
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
mabcampath alemtuzumabas
mabcampath alemtuzumab
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
veiklioji medžiaga yra alemtuzumabas.
the active substance is alemtuzumab.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
alemtuzumabas nepažeidžia kamieninių ir ląstelių pirmtakų.
alemtuzumab does not appear to damage haematopoietic stem cells or progenitor cells.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
lemtrada 12 mg koncentratas infuziniam tirpalui alemtuzumabas
lemtrada 12 mg concentrate for solution for infusion alemtuzumab
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nežinoma, ar alemtuzumabas išsiskiria į motinos pieną.
it is unknown whether alemtuzumab is excreted in human milk.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
veiklioji mabcampath medžiaga alemtuzumabas yra monokloninis antikūnas.
the active substance in mabcampath, alemtuzumab, is a monoclonal antibody.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
mabcampath 10 mg/ml koncentratas infuziniam tirpalui alemtuzumabas
mabcampath 10 mg/ml concentrate for solution for infusion alemtuzumab
Last Update: 2017-04-26
Usage Frequency: 9
Quality:
mabcampath veiklioji medžiaga, alemtuzumabas, yra monokloninis antikūnas.
the active substance in mabcampath, alemtuzumab, is a monoclonal antibody.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
alemtuzumabas 30 mg/ml kiekviename buteliuke yra 30 mg alemtuzumabo
alemtuzumab 30mg per ml each vial contains 30mg alemtuzumab
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
mabcampath 10 mg/ml koncentratas infuziniam tirpalui alemtuzumabas vartoti ven
mabcampath 10 mg/ml concentrate for solution for infusion intravenous use
Last Update: 2008-03-04
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
mabcampath 10 mg/ ml koncentratas infuziniam tirpalui alemtuzumabas vartoti į veną
mabcampath 10 mg/ ml concentrate for solution for infusion alemtuzumab intravenous use
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
alemtuzumabas nėra skirtas vaikams nuo gimimo iki mažiau kaip 10 metų išsėtinei sklerozei gydyti.
there is no relevant use of alemtuzumab in children aged from birth to less than 10 years for the treatment of multiple sclerosis.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
alemtuzumabas susijungia su limfocito pavirsiuje esanciu glikoproteinu (cd52) ir suardo limfocit.
alemtuzumab has been designed to bind to a glycoprotein (cd52) that is found on the surface of lymphocytes.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
alemtuzumabas nepazeidzia kamienini ir lsteli pirmtak.pirm kart gydomi pacientai, sergantys b-lll
alemtuzumab does not appear to damage haematopoietic stem cells or progenitor cells.
Last Update: 2008-03-04
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
alemtuzumabas susijungia su limfocitų paviršiuje esančiu glikoproteinu (cukraus molekulėmis padengtu baltymu), vadinamuoju cd52.
alemtuzumab has been designed to attach to a glycoprotein (a protein that is coated with sugar molecules) called cd52 that is found on the surface of lymphocytes.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
alemtuzumabas yra monokloninis antikūnas, gautas rekombinantinės dnr technologijos būdu, gaminamas žinduolių (kiniškojo žiurkėno kiaušidžių) ląstelių kultūroje, suspenduotoje, maitinamojoje terpėje.
alemtuzumab is a monoclonal antibody produced in mammalian cell (chinese hamster ovary) suspension culture in a nutrient medium by recombinant dna technology.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kiekvienoje ampulėje yra 30 mg alemtuzumabo
each ampoule contains 30 mg of alemtuzumab.
Last Update: 2017-04-26
Usage Frequency: 6
Quality: